News

Tumor microenvironment acts as a mechanism of resistance to chemotherapy in colorectal cancer

A new study highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the fourth most common cancer and the leading cause of cancer death worldwide.

Leer más about Tumor microenvironment acts as a mechanism of resistance to chemotherapy in colorectal cancer

The first epigenetic test to identify tumors of unknown primary

The EPICUP® test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP) Article Esteller M The Lancet Oncology

Leer más about The first epigenetic test to identify tumors of unknown primary

Not all tumor cells are equal

Scientists find that colorectal tumors present epigenetic heterogeneity relates to the clinical course of the disease. Article citation Esteller M Gastroenterology

Leer más about Not all tumor cells are equal

Alvaro Aytes receives one of 60 grants from the BBVA Foundation for researchers and creators

With this initiative, the BBVA Foundation promotes individual effort for the collective benefit of professionals in an intermediate stage of his career and who have demonstrated high productivity and innovativeness the BBVA Foundation has awarded one of the Grants for Researchers and Cultural Creators

Leer más about Alvaro Aytes receives one of 60 grants from the BBVA Foundation for researchers and creators

Manel Esteller, Joan Massagué and Josep Baselga are awarded the Catalunya International Prize

The oncologists Manel Esteller, Joan Massagué and Josep Baselga are the winners of the 28th Catalunya International Prize “for his revolutionary task, especially on oncology research, with what they significantly contributed to the advances of global medicine”. The awards, recently announced by the President of the Generalitat de Catalunya (Catalan Government), Carles Puigdemont, are given […]

Leer más about Manel Esteller, Joan Massagué and Josep Baselga are awarded the Catalunya International Prize

New IDSA/ATS guidelines say less antibiotics for hospital-acquired, ventilator-associated pneumonia

Dr Jordi Carratalà, IDIBELL researcher, is a member of the international panel that created these new guidelines published by the Infectious Diseases Society of America and the American Thoracic Society.

Leer más about New IDSA/ATS guidelines say less antibiotics for hospital-acquired, ventilator-associated pneumonia

Tractivus, ACCIÓ Investment Forum Award finalist

ACCIÓ Investment Forum presentation of Tractivus main meeting points between entrepreneurs and investors in Catalonia Joan Gilabert, CEO of Tractivus, presented in a one-minute-long elevator pitch their design project of 3D-printed custom and antibacterial medical devices 3rd runner-up 400 networking meetings IDIBELL had an active participation, introducing the projects that make up its portfolio of proposals for innovation and technology transfer Alon Lifshitz companies and investors from Israel Enterprise Catalog 2016 top 50 business projects

Leer más about Tractivus, ACCIÓ Investment Forum Award finalist
Scroll to Top